NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









MOBILion Systems

MOBILion Systems

Private
PennsylvaniaHealthcare & Life Scienceshttps://www.mobilionsystems.com/

Last Round

Series C

Jul 13, 2021

Total Funding Raised

$114.8M

Company Overview

MOBILion Systems is a biotechnology company that develops advanced analytical instrumentation devices to enhance disease prediction, diagnosis, and treatment through rapid and sensitive detection of clinically relevant molecules.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Drug Discovery, Biotechnology, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

ion mobility-mass spectrometryHRIMhigh-resolution ion mobilitymass spectrometrybiopharmaceutical instrumentationproteomicsglycomicsmetabolomicsanalytical chemistrySLIMstructures for lossless ion manipulationdrug discovery toolslab equipmentmolecular characterizationbiotech hardwaremass spec

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MOBILion Systems Comps

Public and private peers based on sector, stage, and business model.

MOBILion Systems comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

MOBILion Systems Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CJul 13, 2021
GrantNov 10, 2020
Series BAug 17, 2020
DebtApr 15, 2020
Series ANov 12, 2019
Seed
Apr 11, 2019

Key People

Founding team and executive leadership

Melissa Sherman

Chief Executive Officer

Executive Team

Daniel DeBord

Chief Technology Officer

Executive Team

Craig Carra

Chief Financial Officer

Executive Team

MOBILion Systems Investors

Notable investors and investment history

MOBILion Systems investors
InvestorRounds
iSelect FundSeries A
IP GroupSeries A, Series C, Series B
Hostplus Superannuation FundSeries A, Series C, Series B
Shake it Up Australia FoundationGrant
Cultivation CapitalSeries A, Series C, Series B
D1 Capital PartnersSeries C
aMoonSeries C, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 27, 2025

    Next-generation proteomics platform to be revealed at ASMS 2025.

  • May 27, 2025

    Will attend ASMS 2025 to highlight customer use cases and new platform plans.

MOBILion Systems Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

MOBILion Systems Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MOBILion Systems's valuation, stock price, and market status.

Firmographic Details

HeadquartersPennsylvania
Employee Range44
Year Founded2015
Last FundingJul 13, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.